Uncategorized

Best Buy (NYSE: BBY) has reported disappointing third-quarter results, citing weakened consumer spending ahead of the US presidential election and macroeconomic uncertainties. Revenue fell to US$9.45bn, missing analysts’ expectations of US$9.63bn, while adjusted earnings per share (EPS) came in at US$1.26, short of the projected US$1.29. Comparable store sales declined by 2.9% year-over-year, marking the […]

Richard Brennan, Strategy Ambassador for East Coast Capital Management (ECCM), speaks to Chris Gosselin, CEO of Australian Fund Monitors. Topics discussed include: the success of ECCM’s trend-following strategy, which recently earned an award for the company’s flagship fund; and how global diversification and a focus on trending opportunities can enable consistent performance even in uncertain

President-elect Donald Trump has announced plans to impose significant tariffs on goods from Mexico, Canada, and China immediately upon taking office on 20 January. Citing concerns over illegal immigration and the fentanyl crisis, Trump pledged a 25% tariff on all imports from Mexico and Canada and an additional 10% tariff on Chinese goods, escalating tensions

Sequoia Financial Group Limited (ASX:SEQ) Managing Director and CEO Garry Crole and Chairman Mike Ryan present at the company’s 2024 AGM. FY24 result highlights: Revenue: $124.6m, +26% on PCP Operating profit: $8.7m, +88% on PCP NPAT: $24.0m, +1,012% on PCP Operating cashflow: $4.8m, +69% on PCP DPS: 4.5 CPS (normal) Net cash: $16.8m, +79% on

Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.

Gentrack Group (ASX:GTK) has delivered impressive revenue growth for the year ending 30 September 2024, with group revenue rising 25.5% from $169.9m in 2023 to $213.2m. This was driven by strong demand across its utilities and airport management software segments, bolstered by new customer wins and upgrades. However, cost pressures tempered the overall results. EBITDA remained

A broad stock rally propelled the Dow Jones, S&P 500, and small-cap focused Russell 2000 index to new record highs on Monday. Investors were optimistic that President-elect Donald Trump’s selection for Treasury Secretary, Scott Bessent, would steer the economy effectively without triggering inflation. The Dow rose 440.06 points, or 0.99 per cent, to 44,736.57. The

INOVIQ (ASX:IIQ) has received a $1.018m refund under the Australian Government’s Research & Development (R&D) Tax Incentive program for the fiscal year ending 30 June 2024. The refund reflects $2.7m spent on eligible R&D activities, excluding certain overseas expenditures. The Melbourne-based company specialises in developing diagnostics and therapeutics for cancer. Among its advancements is the

Altech Batteries (ASX:ATC) has signed a second Offtake Letter of Intent for its CERENERGY GridPack Battery Energy Storage System, marking a significant step in its commercialisation efforts. The agreement is with Referenzkraftwerk Lausitz GmbH (RefLau), a joint venture between German renewable energy firms Enertrag SE and Energiequelle GmbH. This follows Altech’s initial offtake agreement, announced

Respiri (ASX:RSH) has announced a binding agreement to acquire the business and assets of Orb Health Inc, a Texas-based provider of remote patient monitoring (RPM) and chronic care management (CCM) services. The acquisition, valued at US$9m, is a pivotal move for Respiri as it expands its footprint in the US healthcare market. Orb Health is